Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe Asthma
Clinical trial NCT05104892 · COMPLETED
Trial details
- NCT number
- NCT05104892
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-12
- Primary completion
- 2024-02-06
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.